CBL vs VRTX · P/E 8.6, rev $515.6M vs P/E 30, rev $12.00B
CBL & Associates Properties Inc (CBL) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
CBL & Associates Properties Inc (CBL) is a reit - retail company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported CBL revenue for 2024-12-31 was $515.6M. Net income was $57.1M. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. CBL currently screens at market cap $1.48B and trailing P/E 8.6.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
CBL currently screens at market cap $1.48B and trailing P/E 8.6. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the CBL and VRTX stock pages for the full models.
Not investment advice.